— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Twice as many Swedes as Brits survive lung cancer
The odds of surviving lung cancer are significantly higher in Norway and Sweden than they are in England, reveals a comparison of the three countries published in Thorax today.
This is despite the fact that healthcare spend and infrastructure in each of these countries are similar, says the study.
The researchers base their findings on five year survival rates for lung cancer patients in Norway, Sweden, and England, all of whom were diagnosed between 1996 and 2004.
During this period 250,828 patients were diagnosed in England, 18,386 in Norway, and 24,886 in Sweden, according to data from lung cancer registries in all three countries.
Survival rates were lowest in England and highest in Sweden, irrespective of age, sex, and length of monitoring period, all of which are known to affect outcome.
Almost twice as many Swedish lung cancer patients survived five years as did their English counterparts, the data show.
Set against the expected survival for a given age, 11.3% of Swedish men diagnosed with lung cancer survived five years. This compares with 9.3% of Norwegian men and 6.5% of English men with the disease.
Comparable figures for women still showed England lagging behind Norway and Sweden.
In Sweden just under 16% of women diagnosed with lung cancer survived five years compared with 13.5% of those diagnosed in Norway and just 8.4% of those diagnosed in England.
The difference in death rates seemed to be concentrated largely in the first year after diagnosis, the study shows.
The chances of a lung cancer patient in England dying in the first three months after diagnosis between 2001 and 2004 were between 23% and 46% higher than they were for a patient in Norway, depending on age and sex.
And they were between 56% and 91% higher than for a patient in Sweden.
The authors cite data, showing that patients in England are less likely to be actively treated with surgery and drugs than their Scandinavian counterparts. This may be because symptom awareness is poor in England, and patients delay seeking medical help, so that by the time they do, their disease is already advanced and beyond curative treatment, they suggest.
They add that the number of diagnoses and deaths from lung cancer in England has plummeted since the 1970s, and that the prevalence of smoking - a key risk factor for lung cancer - is higher in the UK than it is in either Norway or Sweden.
'However, we cannot exclude that differences in treatment activity - related or not to [other co-existing illness] - play a role,' they conclude.
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Gene variant increases risk of asthma
Secrets of cellular signalling shed light on novel cancer stem cell therapies
Needle-size device created to track tumours, radiation dose
Long-term data show vertebroplasty for osteoporotic spinal fractures provides dramatic pain relief